| Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia K Agrawal, S Bhadada, BR Mittal, J Shukla, A Sood, A Bhattacharya, ... Clinical nuclear medicine 40 (1), e6-e10, 2015 | 102 | 2015 |
| Development of Lu‐177‐trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients P Bhusari, R Vatsa, G Singh, M Parmar, A Bal, DK Dhawan, BR Mittal, ... International journal of cancer 140 (4), 938-947, 2017 | 78 | 2017 |
| Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog N Dubey, R Varshney, J Shukla, A Ganeshpurkar, PP Hazari, ... Drug delivery 19 (3), 132-142, 2012 | 67 | 2012 |
| 177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial S Satapathy, BR Mittal, A Sood, CK Das, RS Mavuduru, S Goyal, J Shukla, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-11, 2022 | 43 | 2022 |
| Molecular imaging targeting corticotropin-releasing hormone receptor for corticotropinoma: a changing paradigm R Walia, R Gupta, A Bhansali, R Pivonello, R Kumar, H Singh, C Ahuja, ... The Journal of Clinical Endocrinology & Metabolism 106 (4), 1816-1826, 2021 | 43 | 2021 |
| Detailed evaluation of different 68Ge/68Ga generators: an attempt toward achieving efficient 68Ga radiopharmacy R Chakravarty, S Chakraborty, R Ram, R Vatsa, P Bhusari, J Shukla, ... Journal of Labelled Compounds and Radiopharmaceuticals 59 (3), 87-94, 2016 | 43 | 2016 |
| PLGA nanoparticles for peptide receptor radionuclide therapy of neuroendocrine tumors: a novel approach towards reduction of renal radiation dose G Arora, J Shukla, S Ghosh, SK Maulik, A Malhotra, G Bandopadhyaya PLoS One 7 (3), e34019, 2012 | 42 | 2012 |
| 68Ga-DOTA-RGD2 Positron Emission Tomography/Computed Tomography in Radioiodine Refractory Thyroid Cancer: Prospective Comparison of Diagnostic Accuracy with … AS Parihar, BR Mittal, R Kumar, J Shukla, A Bhattacharya Thyroid 30 (4), 557-567, 2020 | 41 | 2020 |
| 18F-FDG and 18F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes SJ Rayamajhi, BR Mittal, VN Maturu, R Agarwal, A Bal, P Dey, J Shukla, ... Annals of nuclear medicine 30, 207-216, 2016 | 39 | 2016 |
| Nonspecific uptake of 68Ga-prostate-specific membrane antigen in diseases other than prostate malignancy on positron emission tomography/computed tomography imaging: a … D Malik, A Sood, BR Mittal, H Singh, RK Basher, J Shukla, A Bhattacharya, ... Indian Journal of Nuclear Medicine 33 (4), 317-325, 2018 | 37 | 2018 |
| Role of rhenium-188 tin colloid radiosynovectomy in patients with inflammatory knee joint conditions refractory to conventional therapy SA Shamim, R Kumar, D Halanaik, A Kumar, V Shandal, J Shukla, ... Nuclear Medicine Communications 31 (9), 814-820, 2010 | 33 | 2010 |
| Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS AS Parihar, A Sood, R Kumar, P Bhusari, J Shukla, BR Mittal European Journal of Nuclear Medicine and Molecular Imaging 45, 1836-1837, 2018 | 31 | 2018 |
| Quality control of positron emission tomography radiopharmaceuticals: An institutional experience J Shukla, R Vatsa, N Garg, P Bhusari, A Watts, BR Mittal Indian Journal of Nuclear Medicine 28 (4), 200-206, 2013 | 30 | 2013 |
| 68Ga-DOTATATE positron emission tomography/computed tomography scan in the detection of bone metastases in pediatric neuroendocrine tumors R Goel, J Shukla, D Bansal, K Sodhi, A Bhattacharya, RK Marwaha, ... Indian Journal of Nuclear Medicine 29 (1), 13-17, 2014 | 24 | 2014 |
| Characterization of Re-188–Sn microparticles used for synovitis treatment J Shukla, GP Bandopadhyaya, SA Shamim, R Kumar International journal of pharmaceutics 338 (1-2), 43-47, 2007 | 22 | 2007 |
| Dimercaptosuccinic acid: A multifunctional cost effective agent for imaging and therapy J Shukla, BR Mittal Indian journal of nuclear medicine 30 (4), 295-302, 2015 | 21 | 2015 |
| Evaluation of cytotoxic and tumor targeting capability of 177Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy G Arora, P Dubey, J Shukla, S Ghosh, G Bandopadhyaya Annals of nuclear medicine 30, 334-345, 2016 | 20 | 2016 |
| Integrin αvβ3 as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter 68Ga-Labeled DOTA-Arginine-Glycine … R Vatsa, P Bhusari, S Kumar, S Chakraborty, A Dash, G Singh, ... Cancer Biotherapy and Radiopharmaceuticals 30 (5), 217-224, 2015 | 20 | 2015 |
| Toward realization of ‘mix-and-use’approach in 68Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of 68Ga-labeled NODAGA-coupled RGD peptide … S Chakraborty, R Chakravarty, R Vatsa, P Bhusari, HD Sarma, J Shukla, ... Nuclear Medicine and Biology 43 (1), 116-123, 2016 | 18 | 2016 |
| Comparative performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT imaging in patients with Parkinson’s disease, Parkinson-plus syndrome, and essential tremor A Sood, J Shukla, R Shree, R Vatsa, M Modi, BR Mittal Clinical Nuclear Medicine 46 (2), 95-102, 2021 | 17 | 2021 |
Bhagwant Rai MittalProfessor of Nuclear MedicineEmail confirmado em pgimer.edu.in